These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7478598

  • 1. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD, Stewart JP, Arrand JR, Mackett M.
    Oncogene; 1995 Nov 02; 11(9):1711-9. PubMed ID: 7478598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C.
    Hum Antibodies Hybridomas; 1993 Apr 02; 4(2):66-73. PubMed ID: 8390865
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
    Wu Y, Maruo S, Yajima M, Kanda T, Takada K.
    J Virol; 2007 Oct 02; 81(20):11236-45. PubMed ID: 17686859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan 02; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C, Zubler RH.
    J Immunol; 1989 Jan 01; 142(1):87-93. PubMed ID: 2535862
    [Abstract] [Full Text] [Related]

  • 11. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E, Tsoukas CD, Vaughan JH, Altman A, Carson DA.
    J Immunol; 1983 Jan 01; 130(1):169-72. PubMed ID: 6292301
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A.
    Immunology; 2006 Mar 01; 117(3):379-85. PubMed ID: 16476057
    [Abstract] [Full Text] [Related]

  • 13. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C, Lavoué MF, Patet J, de-Thé G.
    Biomedicine; 1979 Jun 01; 30(2):102-8. PubMed ID: 224964
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Jun 01; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.
    Blomhoff HK, Smeland E, Mustafa AS, Godal T, Ohlsson R.
    Eur J Immunol; 1987 Feb 01; 17(2):299-301. PubMed ID: 3030769
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep 01; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 19. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):686-90. PubMed ID: 9837767
    [Abstract] [Full Text] [Related]

  • 20. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L, Kieran J, Boyle P, Wetzel GD.
    Hum Antibodies; 1997 Nov 27; 8(1):43-7. PubMed ID: 9265505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.